Dubai: Aramex on Tuesday announced its partnership with NewBridge Pharmaceuticals.
As part of this collaboration, Aramex said it is now providing a range of logistics services for NewBridge in the Middle East, Africa, Canada and the UK.
Through the partnership, Aramex is managing the logistics of patient samples across any clinics and hospitals from the Middle East to the US for advanced clinical testing, the company said in a statement.
Aramex is also providing temperature-controlled storage and transportation of medication for NewBridge from various distribution hubs in the UK and Canada to health care facilities within the Middle East and Africa.
“This partnership with Aramex gives us significant opportunities to expand our business proposition and take advantage of the increasing demand for our solutions across the Middle East and Africa,” Joe Henein, CEO of NewBridge Pharmaceuticals, said in a statement.
In addition to having facility hubs based in the UK and Canada, Aramex said it plans to set up a third facility hub in the US soon, and will continue to handle the storage, transport and delivery of NewBridge’s medicine and other pharmaceutical goods.
“By working closely with NewBridge, we are able to further penetrate the health care market, take advantage of the increased demand for logistics services in the pharmaceutical industry and better support people who require medicine and other pharmaceutical needs to be delivered to them effectively and efficiently,” stated Hussein Hachem, CEO of Aramex.